Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
. 2022 Jun 16;162(7):S-1007. doi: 10.1016/S0016-5085(22)62389-8

Tu1551: PATIENTS WITH INFLAMMATORY BOWEL DISEASES HAVE IMPAIRED ANTIBODY PRODUCTION AFTER ANTI-SARS-COV-2 VACCINATION, ESPECIALLY THOSE ON ANTI-TNFα OR COMBINATION TREATMENT OF BIOLOGICS PLUS IMMUNOMODULATORS: RESULTS FROM A PANHELLENIC REGISTRY

Eirini Zacharopoulou, Eleni Orfanoudaki, Vassiliki Kitsou, Maria Tzouvala, George Tribonias, Gerassimos J Mantzaris, Nikos Viazis, Angeliki Christidou, Tereza Georgiadi, Konstantinos Karmiris, Angeliki Theodoropoulou, Maria Tsafaridou, Spyridon Michopoulos, Evanthia Zampeli, Evgenia Papathanasiou, Georgios Michalopoulos, Stefanos Tigkas, Pantelis Karatzas, Effrosyni Laoudi, Christos Liatsos, Nikolaos Kyriakos, Iordanis Mylonas, Georgios J Theocharis, Theodora Kafentzi, Ioannis E Koutroubakis, Giorgos Bamias
PMCID: PMC9212535

The content is available as a PDF (1.1 MB).


Articles from Gastroenterology are provided here courtesy of Elsevier

RESOURCES